活动信息

Current Management of Diabetic Eye Diseases

日期: 2017-03-21
媒体:

The Event

Dr. Seenu M. Hariprasad, Shui-Chin Lee Professor of Ophthalmology and Visual Science at The University of Chicago Medicine, discussed the pathophysiology and current management of diabetic retinopathy and diabetic macular edema. He discussed the evolution of several therapies including retina laser photocoagulation, anti-vascular endothelial growth factor agents and corticosteroids. Dr. Hariprasad also presented clinical trial data including the DRCR Network Protocol-T study.  He concluded with a case presentation and a discussion session.

Registration/ 注册: 18:30 – 19:00

Talk and Q&A/ 演讲与问答: 19:00 – 20:30

Light Refreshments/ 简餐: 20:30 – 21:00

 

Speaker Bio

Since joining the University of Chicago Medicine in 2005, Dr. Hariprasad has gained a reputation as a leading specialist in various vitreoretinal disorders, including AMD, diabetic eye disease, intraocular infection and RVO. He has been recognized for bringing more effective and efficient sutureless microincisional vitrectomy techniques to the medical center.

Dr. Hariprasad’s clinical research has contributed to the understanding and use of new medications to combat a wide variety of vitreoretinal disorders. He has served as principal or sub-investigator in more than 45 national and international clinical trials evaluating various medications, sustained drug-delivery devices and surgical innovations to treat a variety of diseases, such as AMD, diabetic retinopathy and RVO.


Cookie声明
我们使用 Cookie来提高网站性能,促进信息共享,并根据您的兴趣提供广告。如需了解更多信息,请参阅我们的网站隐私政策。您也可以自定义网络浏览器的 Cookie设置。请注意,如果您拒绝接受 Cookie,可能会影响网站的功能和性能。

拒绝
同意